Keyword: CAS Registry Number: 21187-98-4
Standard: EP6
Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. It is marketed as Glyloc and Reclide in India and Diamicron in Canada. In the Philippines, it is marketed as Glubitor-OD. It is not marketed in the United States. A modified-release formulation is also marketed. Its classification has been ambiguous, as literature uses it as both a first-generation and second-generation sulfonylurea. Each tablet contains 80, 60, or 30 mg of gliclazide. In the Philippines, it is only available in 30 mg or 80 mg doses。
SPECIFICATION: Properties
Hypoglycemic sulfonylurea, restoring first peak of insulin secretion, increasing insulin sensitivity. Glycemia-independent hemovascular effects, antioxidant effect. No active circulating metabolites. Gliclazide is used for control of hyperglycemia in gliclazide-responsive diabetes mellitus of stable, mild, non-ketosis prone, maturity-onset or adult type.
Statistics: Companies: 641,900+, Trade Leads: 160,500+, Products: 104,300+, Contacts / Replies: 8,279,300+ There are currently 15562 users online browsing our B2B network. 1:21 GMT, Friday, May 17, 2024 Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and 1st World Trade Portal and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.